Pernix Therapeutics Holdings, Inc. PTX, a specialty pharmaceutical company, announced today that Douglas Drysdale, Chairman, President and Chief Executive Officer and Sanjay Patel, Chief Financial Officer, are scheduled to present at the Annual Piper Jaffray Healthcare Conference in New York, NY on December 2, 2014.
Event: | 26th Annual Piper Jaffray Healthcare Conference | ||
Date: |
Tuesday, December 2, 2014 |
||
Time: | 10:30-11:30 AM EST | ||
A live webcast of the presentation will be available on the Pernix Therapeutics website, www.pernixtx.com, under the investor relations tab. A replay of the webcast will be available for 30 days after the date of presentation.
About Pernix Therapeutics
Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and psychiatry, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its Pernix sales force, uses contracted sales organizations to market its non-core, cough and cold products, and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.
To learn more about Pernix Therapeutics, visit www.pernixtx.com.
Pernix Therapeutics Holdings Inc.
Investor
Relations
Sanjay Patel, (800) 793-2145 ext. 1009
Chief
Financial Officer
spatel@pernixtx.com
or
Doug
Drysdale, (800) 793-2145 ext. 1001
Chairman, President and Chief
Executive Officer
ddrysdale@pernixtx.com
or
Media
Relations
Marianne Lambertson, (800) 793-2145 ext. 1012
Vice
President, Marketing and Corporate Communications
mlambertson@pernixtx.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.